Coya Therapeutics

Nobel Prize medal with background of 100 bills
Research

How Nobel-winning cells could become a 'universal drug'

With their broad ability to tamp down immune activity, regulatory T cells could potentially be harnessed to treat just about any inflammatory disease.
Darren Incorvaia Oct 21, 2025 2:00pm
photo of a green light on a stoplight

After delay, Coya receives FDA go-ahead for phase 2 ALS trial

Aug 25, 2025 11:04am
delay

FDA delays hit clinical trial launch decisions

Jul 30, 2025 10:29am
Graphic image of puzzle pieces missing from a persons brain a symbol of degeneration andor the improvement of it

Coya shares data on IL-2 prospect in small Alzheimer's study

Oct 29, 2024 7:55am
Paragliding over the cliffs Fort Funston San Francisco

BioMarin builds exec team with biotech vets—Chutes & Ladders

Aug 23, 2024 8:30am
cash runway cash airplane extend deal earnings

Coya taps familiar friend Dr. Reddy's to commercialize ALS med

Dec 6, 2023 11:20am